The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry

Incidence and prevalence of pulmonary arterial hypertension in Germany

(2016) Marius M. Hoeper et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN RESPIRATORY JOURNAL

Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance

(2015) Harrison W. Farber et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis

(2015) Raymond L. Benza et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Baseline and Follow-up 6-Min Walk Distance and Brain Natriuretic Peptide Predict 2-Year Mortality in Pulmonary Arterial Hypertension

(2013) Jason S. Fritz et al.   CHEST

Evaluation of the Predictive Value of a Clinical Worsening Definition Using 2-Year Outcomes in Patients With Pulmonary Arterial Hypertension

(2013) Adaani E. Frost et al.   CHEST

Anticoagulation and Survival in Pulmonary Arterial Hypertension

(2013) Karen M. Olsson et al.   CIRCULATION

Definitions and Diagnosis of Pulmonary Hypertension

(2013) Marius M. Hoeper et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Treatment Goals of Pulmonary Hypertension

(2013) Vallerie V. McLaughlin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Riociguat for the Treatment of Pulmonary Arterial Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Minimal Important Difference in the 6-Minute Walk Test for Patients with Pulmonary Arterial Hypertension

(2012) Stephen C. Mathai et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Validation of 6-Minute Walk Distance as a Surrogate End Point in Pulmonary Arterial Hypertension Trials

(2012) Nicole B. Gabler et al.   CIRCULATION

Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension?

(2012) Gianluigi Savarese et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

(2010) A. J. Tyndall et al.   ANNALS OF THE RHEUMATIC DISEASES

Predicting Survival in Pulmonary Arterial Hypertension

(2010) Raymond L. Benza et al.   CIRCULATION

Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

(2010) Marc Humbert et al.   CIRCULATION

The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension

(2010) W.-T. N. Lee et al.   EUROPEAN RESPIRATORY JOURNAL

Tadalafil Therapy for Pulmonary Arterial Hypertension

(2009) Nazzareno Galiè et al.   CIRCULATION

Internationales, prospektives Register zur Erfassung der Initial- und Dauertherapie von Patienten mit pulmonaler Hypertonie (CompERA-XL)

(2009) D Pittrow et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

(2009) et al.   EUROPEAN HEART JOURNAL

End Points and Clinical Trial Design in Pulmonary Arterial Hypertension

(2009) Vallerie V. McLaughlin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

(2009) Vallerie V. McLaughlin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Inflammation, Growth Factors, and Pulmonary Vascular Remodeling

(2009) Paul M. Hassoun et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Estimating a Minimally Important Difference in Pulmonary Arterial Hypertension Following Treatment With Sildenafil

(2008) Claire Gilbert et al.   CHEST

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

(2008) Nazzareno Galiè et al.   CIRCULATION

Sex-specific Predictive Power of 6-Minute Walk Test in Chronic Heart Failure Is Not Enhanced Using Percent Achieved of Published Reference Equations

(2008) Lutz Frankenstein et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Gender and age related predictive value of walk test in heart failure: Do anthropometrics matter in clinical practice?

(2007) L. Frankenstein et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY